Page 25 of articles about health in Press releases

The recent discovery of Aujeszky’s Disease in pigs in the Pyrenees Atlantic region of France reminds us that we cannot take the absence of notifiable diseases for granted.

EXCEDE® is now approved by the U.S. Center for Veterinary Medicine and the Food and Drug Administration for the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis in groups of pigs where SRD has been diagnosed.

Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.

During the recent 21st International Pig Veterinary Society (IPVS) Congress in Vancouver, Canada, Novartis Animal Health sponsored a satellite symposium entitled: “Management of pneumo-enteric infections including vector control”

Sanofi-aventis and Merck & Co., Inc. announced today that Raul E. Kohan will be appointed Chief Executive Officer of their proposed Animal Health joint venture. Sanofi-aventis and Merck - known as MSD outside the United States and Canada - intend to combine Merial with Intervet/Schering-Plough, to create a new global leader in Animal Health to be called Merial-Intervet.

Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.

The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.

With the launch of Ingelvac CircoFLEX® by Boehringer Ingelheim on the Russian market, pig producers in Russia now have access to the world’s market leading vaccine against porcine Circovirus type 2 (PCV2).

Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) concluded the referral procedure for PORCILIS® PRRS and for PORCILIS® M Hyo on simultaneous administration of these products in piglets

H1N2, H1N1 and H3N2 are the three influenza A virus subtypes of the Swine Influenza virus contained in GRIPOVAC®3, a new vaccine against swine influenza.

IDT Biologika has developed and is marketing the first swine influenza vaccine - Respiporc Flu3 - registered for protection against the three most clinically significant subtypes of the virus, H1N1, H3N2 and H1N2.

The American Association of Swine Veterinarians is pleased to announce the publication of the 4th edition of the Swine Disease Manual, edited by Drs. Eric Neumann, Alex Ramirez, and Kent Schwartz.

Despite years of hard work by scientists, researchers, practicing veterinarians, pork producers, animal health companies, and others, Porcine Reproductive and Respiratory Syndrome (PRRS) remains a costly, frustrating challenge to the global swine industry.

Diseases associated with PCV2 infection (PCVD) belong to the most devastating diseases in swine worldwide. Fortunately, since a few years, losses attributed to this disease complex can be controlled very effectively by vaccinating piglets.

As part of its ongoing global expansion, animal health and nutrition company, Alltech, has announced the opening of its first office in Spain.

A new disease which poses as great a risk as foot-and-mouth disease could devastate the British pig industry unless controls are tightened up.